Skip to main navigation
ContraVir Pharmaceuticals
  • About
    • Company Overview
    • Leadership
    • Board of Directors
    • Partnering
  • Pipeline
    • Drug Candidates
      • TXL™ (CMX157)
      • CRV431
      • Valnivudine™ (FV-100)
    • Disease Areas
      • Chronic Hepatitis B
      • Shingles
    • Clinical Trials
    • Scientific Literature
    • Intellectual Property
  • Newsroom
    • Press Releases
    • Newsroom
      • All Media Placements
      • Videos
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials & Filings
      • SEC Filings
      • Fundamentals
      • Annual Reports & Proxy Statements
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
      • Search Investors
  • Contact
    • Contact Us
    • Careers
Press enter to begin your search

Main navigation

  • About
    • Company Overview
    • Leadership
    • Board of Directors
    • Partnering
  • Pipeline
    • Drug Candidates
      • TXL™ (CMX157)
      • CRV431
      • Valnivudine™ (FV-100)
    • Disease Areas
      • Chronic Hepatitis B
      • Shingles
    • Clinical Trials
    • Scientific Literature
    • Intellectual Property
  • Newsroom
    • Press Releases
    • Newsroom
      • All Media Placements
      • Videos
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials & Filings
      • SEC Filings
      • Fundamentals
      • Annual Reports & Proxy Statements
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
      • Search Investors
  • Contact
    • Contact Us
    • Careers
Menu

Investor Relations navigation

  • Overview
  • News Releases
  • Events & Presentations
  • Stock Information
  • Financials & Filings
  • Corporate Governance
  • Investor Resources

NobleCon14

NobleCon14

Jan 29 - Jan 30, 2018

Listen to webcast
Get Important News and Updates by Email Subscribe

© 2018 ContraVir Pharmaceuticals | Disclaimer & Terms of Use